<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font21 { font-size : 21; } .font10 { font-size : 10; } .font27 { font-size : 27; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font27">and </span>
   <span class="font21">Notch </span>
   <span class="font14">been </span>
   <span class="font14">has </span>
   <span class="font14">signalling </span>
   <span class="font13">cell </span>
   <span class="font13">that </span>
   <span class="font13">CCA </span>
   <span class="font13">with </span>
   <span class="font13">pathway </span>
   <span class="font12">for </span>
   <span class="font12">are </span>
   <span class="font12">have </span>
   <span class="font11">The </span>
   <span class="font11">development </span>
   <span class="font11">cells </span>
   <span class="font11">signaling </span>
   <span class="font11">liver </span>
   <span class="font11">expression </span>
   <span class="font11">IH-CCA </span>
   <span class="font11">also </span>
   <span class="font11">biliary </span>
   <span class="font11">role </span>
   <span class="font11">{background </span>
   <span class="font11">growth </span>
   <span class="font11">which </span>
   <span class="font11">cancer </span>
   <span class="font11">found </span>
   <span class="font11">its </span>
   <span class="font11">lines </span>
   <span class="font11">activation </span>
   <span class="font11">therapeutic </span>
   <span class="font11">CCA. </span>
   <span class="font11">inhibition </span>
   <span class="font11">tumour </span>
   <span class="font10">human </span>
   <span class="font10">margin </span>
   <span class="font10">significant </span>
   <span class="font10">{border-style </span>
   <span class="font10">hepatic </span>
   <span class="font10">results </span>
   <span class="font10">via </span>
   <span class="font10">cholangiocarcinoma </span>
   <span class="font10">mouse </span>
   <span class="font10">progression </span>
   <span class="font10">px;} </span>
   <span class="font10">receptors </span>
   <span class="font10">#ffffff;} </span>
   <span class="font10">bile </span>
   <span class="font10">overexpression </span>
   <span class="font10">patients </span>
   <span class="font10">treatment </span>
   <span class="font10">intrahepatic </span>
   <span class="font10">other </span>
   <span class="font10">plays </span>
   <span class="font10">receptor </span>
   <span class="font10">study </span>
   <span class="font10">Cell </span>
   <span class="font10">downstream </span>
   <span class="font10">from </span>
   <span class="font10">involved </span>
   <span class="font10">model </span>
   <span class="font10">this </span>
   <span class="font10">Cancer </span>
   <span class="font10">Hes </span>
   <span class="font10">activity </span>
   <span class="font10">into </span>
   <span class="font10">Res </span>
   <span class="font10">This </span>
   <span class="font10">clinical </span>
   <span class="font10">hepatocytes </span>
   <span class="font10">reduces </span>
   <span class="font10">regulation </span>
   <span class="font10">reported </span>
   <span class="font10">Human </span>
   <span class="font10">formation </span>
   <span class="font10">genes </span>
   <span class="font10">inhibits </span>
   <span class="font10">mice </span>
   <span class="font10">observed </span>
   <span class="font10">showed </span>
   <span class="font10">survival </span>
   <span class="font10">through </span>
   <span class="font10">various </span>
   <span class="font10">Biol </span>
   <span class="font10">JAG- </span>
   <span class="font10">cascade </span>
   <span class="font10">duct </span>
   <span class="font10">effects </span>
   <span class="font10">gene </span>
   <span class="font10">important </span>
   <span class="font10">incidence </span>
   <span class="font10">molecular </span>
   <span class="font10">target </span>
   <span class="font10">their </span>
   <span class="font10">these </span>
   <span class="font10">hepatocellular </span>
   <span class="font10">higher </span>
   <span class="font10">induces </span>
   <span class="font10">like </span>
   <span class="font10">pathways </span>
   <span class="font10">significantly </span>
   <span class="font10">transcription </span>
   <span class="font10">vitro </span>
   <span class="font10">vivo </span>
   <span class="font10">HCC </span>
   <span class="font10">NICD </span>
   <span class="font10">apoptosis </span>
   <span class="font10">can </span>
   <span class="font10">effect </span>
   <span class="font10">fate </span>
   <span class="font10">inhibiting </span>
   <span class="font10">inhibitor </span>
   <span class="font10">notch </span>
   <span class="font10">potential </span>
   <span class="font10">risk </span>
   <span class="font10">tumor </span>
   <span class="font10">tumours </span>
   <span class="font10">Cholangiocarcinoma </span>
   <span class="font10">Hedgehog </span>
   <span class="font10">Notch, </span>
   <span class="font10">antibodies </span>
   <span class="font10">chronic </span>
   <span class="font10">dependent </span>
   <span class="font10">derived </span>
   <span class="font10">function </span>
   <span class="font10">further </span>
   <span class="font10">inactivation </span>
   <span class="font10">key </span>
   <span class="font10">levels </span>
   <span class="font10">ligand </span>
   <span class="font10">ligands </span>
   <span class="font10">miR- </span>
   <span class="font10">molecules </span>
   <span class="font10">more </span>
   <span class="font10">proliferation </span>
   <span class="font10">px; </span>
   <span class="font10">recognized </span>
   <span class="font10">research </span>
   <span class="font10">studies </span>
   <span class="font10">transcriptional </span>
   <span class="font10">was </span>
   <span class="font10">well </span>
   <span class="font10">{font-family </span>
   <span class="font10">CCA[]. </span>
   <span class="font10">GSI </span>
   <span class="font10">Hence, </span>
   <span class="font10">NOTCH </span>
   <span class="font10">These </span>
   <span class="font10">They </span>
   <span class="font10">addition </span>
   <span class="font10">against </span>
   <span class="font10">anti-Notch </span>
   <span class="font10">associated </span>
   <span class="font10">both </span>
   <span class="font10">critical </span>
   <span class="font10">cycle </span>
   <span class="font10">differentiation </span>
   <span class="font10">factor </span>
   <span class="font10">factors </span>
   <span class="font10">font-size </span>
   <span class="font10">major </span>
   <span class="font10">mechanism </span>
   <span class="font10">miR-, </span>
   <span class="font10">miR-a </span>
   <span class="font10">models </span>
   <span class="font10">rate </span>
   <span class="font10">reduction </span>
   <span class="font10">result </span>
   <span class="font10">significance </span>
   <span class="font10">solid </span>
   <span class="font10">targeting </span>
   <span class="font10">AKT </span>
   <span class="font10">Alb </span>
   <span class="font10">Another </span>
   <span class="font10">Cinobufagin </span>
   <span class="font10">CreERT; </span>
   <span class="font10">EZH </span>
   <span class="font10">Hippo </span>
   <span class="font10">ICC </span>
   <span class="font10">IH-CCA. </span>
   <span class="font10">Phase </span>
   <span class="font10">RBPJ </span>
   <span class="font10">Sci </span>
   <span class="font10">Wnt </span>
   <span class="font10">activated </span>
   <span class="font10">among </span>
   <span class="font10">around </span>
   <span class="font10">but </span>
   <span class="font10">cancer, </span>
   <span class="font10">cells. </span>
   <span class="font10">complex </span>
   <span class="font10">double; </span>
   <span class="font10">expressed </span>
   <span class="font10">genetic </span>
   <span class="font10">induced </span>
   <span class="font10">intracellular </span>
   <span class="font10">leads </span>
   <span class="font10">markers </span>
   <span class="font10">mice[]. </span>
   <span class="font10">migration </span>
   <span class="font10">not </span>
   <span class="font10">novel </span>
   <span class="font10">pathogenesis </span>
   <span class="font10">pathway, </span>
   <span class="font10">per </span>
   <span class="font10">poor </span>
   <span class="font10">process </span>
   <span class="font10">protein </span>
   <span class="font10">rates </span>
   <span class="font10">regulating </span>
   <span class="font10">show </span>
   <span class="font10">stem </span>
   <span class="font10">subsequent </span>
   <span class="font10">such </span>
   <span class="font10">suppression </span>
   <span class="font10">targets </span>
   <span class="font10">trial </span>
   <span class="font10">understanding </span>
   <span class="font10">AKT/Ras </span>
   <span class="font10">Alb-CreERT; </span>
   <span class="font10">CCA, </span>
   <span class="font10">Dev </span>
   <span class="font10">EH-CCA </span>
   <span class="font10">Furthermore, </span>
   <span class="font10">Grade </span>
   <span class="font10">Inhibitor) </span>
   <span class="font10">Kupffer </span>
   <span class="font10">Med </span>
   <span class="font10">Mice </span>
   <span class="font10">Pathol </span>
   <span class="font10">RRNotch/ </span>
   <span class="font10">Rev </span>
   <span class="font10">Secretase </span>
   <span class="font10">Signaling </span>
   <span class="font10">Signalling </span>
   <span class="font10">acid </span>
   <span class="font10">activates </span>
   <span class="font10">all </span>
   <span class="font10">anti-JAG- </span>
   <span class="font10">antibody </span>
   <span class="font10">based </span>
   <span class="font10">between </span>
   <span class="font10">bone </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">canonical </span>
   <span class="font10">carcinoma </span>
   <span class="font10">cells, </span>
   <span class="font10">cellular </span>
   <span class="font10">cholangiocellular </span>
   <span class="font10">common </span>
   <span class="font10">comparing </span>
   <span class="font10">conducted </span>
   <span class="font10">decrease </span>
   <span class="font10">domain </span>
   <span class="font10">down-regulation </span>
   <span class="font10">each </span>
   <span class="font10">established </span>
   <span class="font10">exhibits </span>
   <span class="font10">findings </span>
   <span class="font10">hepatocyte </span>
   <span class="font10">high </span>
   <span class="font10">highly </span>
   <span class="font10">identified </span>
   <span class="font10">include </span>
   <span class="font10">including </span>
   <span class="font10">inhibitory </span>
   <span class="font10">loss </span>
   <span class="font10">many </span>
   <span class="font10">mesenchymal </span>
   <span class="font10">most </span>
   <span class="font10">multiple </span>
   <span class="font10">one </span>
   <span class="font10">pancreatic </span>
   <span class="font10">primary </span>
   <span class="font10">progenitor </span>
   <span class="font10">reduced </span>
   <span class="font10">regulates </span>
   <span class="font10">revealed </span>
   <span class="font10">secretase </span>
   <span class="font10">shown </span>
   <span class="font10">solid; </span>
   <span class="font10">specific </span>
   <span class="font10">specification </span>
   <span class="font10">suppressing </span>
   <span class="font10">than </span>
   <span class="font10">them </span>
   <span class="font10">they </span>
   <span class="font10">transformation </span>
   <span class="font10">trials </span>
   <span class="font10">tumours. </span>
   <span class="font10">tumours[]. </span>
   <span class="font10">types </span>
   <span class="font10">viral </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(Gamma </span>
   <span class="font10">Alagille </span>
   <span class="font10">Also, </span>
   <span class="font10">Clin </span>
   <span class="font10">Demcizumab </span>
   <span class="font10">Development </span>
   <span class="font10">IH-CCA, </span>
   <span class="font10">Inhibitors </span>
   <span class="font10">Jagged- </span>
   <span class="font10">Liver </span>
   <span class="font10">Mol </span>
   <span class="font10">Stem </span>
   <span class="font10">There </span>
   <span class="font10">Xanthohumol </span>
   <span class="font10">[,] </span>
   <span class="font10">activation. </span>
   <span class="font10">acute </span>
   <span class="font10">adult </span>
   <span class="font10">after </span>
   <span class="font10">along </span>
   <span class="font10">and/or </span>
   <span class="font10">antisense </span>
   <span class="font10">approach </span>
   <span class="font10">arrest </span>
   <span class="font10">atypical </span>
   <span class="font10">binding </span>
   <span class="font10">blocking </span>
   <span class="font10">blocks </span>
   <span class="font10">bold </span>
   <span class="font10">carcinogenesis </span>
   <span class="font10">causes </span>
   <span class="font10">central </span>
   <span class="font10">characterized </span>
   <span class="font10">cholangiocarcinogenesis </span>
   <span class="font10">completely </span>
   <span class="font10">component </span>
   <span class="font10">components </span>
   <span class="font10">comprises </span>
   <span class="font10">constitutive </span>
   <span class="font10">conversion </span>
   <span class="font10">courier; </span>
   <span class="font10">current </span>
   <span class="font10">data </span>
   <span class="font10">deletion </span>
   <span class="font10">demonstrated </span>
   <span class="font10">development, </span>
   <span class="font10">disease </span>
   <span class="font10">diseases </span>
   <span class="font10">due </span>
   <span class="font10">during </span>
   <span class="font10">em; </span>
   <span class="font10">employing </span>
   <span class="font10">factor, </span>
   <span class="font10">following </span>
   <span class="font10">form </span>
   <span class="font10">four </span>
   <span class="font10">gamma </span>
   <span class="font10">highest </span>
   <span class="font10">increase </span>
   <span class="font10">increased </span>
   <span class="font10">increasing </span>
   <span class="font10">induce </span>
   <span class="font10">inducing </span>
   <span class="font10">inhibit </span>
   <span class="font10">inhibitors </span>
   <span class="font10">interfering </span>
   <span class="font10">invasion </span>
   <span class="font10">low </span>
   <span class="font10">lung </span>
   <span class="font10">mainly </span>
   <span class="font10">may </span>
   <span class="font10">mechanisms </span>
   <span class="font10">miceHepatology </span>
   <span class="font10">oncogenic </span>
   <span class="font10">part </span>
   <span class="font10">pathway. </span>
   <span class="font10">phase </span>
   <span class="font10">play </span>
   <span class="font10">preclinical </span>
   <span class="font10">prognosis </span>
   <span class="font10">proliferation, </span>
   <span class="font10">promising </span>
   <span class="font10">prostate </span>
   <span class="font10">pt;} </span>
   <span class="font10">receptor: </span>
   <span class="font10">regulator </span>
   <span class="font10">represents </span>
   <span class="font10">response </span>
   <span class="font10">roles </span>
   <span class="font10">selective </span>
   <span class="font10">single </span>
   <span class="font10">strategy </span>
   <span class="font10">studied </span>
   <span class="font10">suppresses </span>
   <span class="font10">targeted </span>
   <span class="font10">that, </span>
   <span class="font10">theta </span>
   <span class="font10">those </span>
   <span class="font10">treated </span>
   <span class="font10">tubulogenesis </span>
   <span class="font10">type </span>
   <span class="font10">under </span>
   <span class="font10">where </span>
   <span class="font10">while </span>
   <span class="font10">will </span>
   <span class="font10">β-hydroxylase </span>
  </p>
 </body>
</html>
